Prometheus Biosciences, Inc.*
|
| 1,734
| 41,113
|
Protagonist Therapeutics, Inc.*
|
| 6,778
| 120,106
|
Prothena Corp. PLC*
|
| 5,236
| 372,960
|
PTC Therapeutics, Inc.* (a)
|
| 10,325
| 384,193
|
Puma Biotechnology, Inc.*
|
| 4,810
| 33,718
|
Radius Health, Inc.*
|
| 7,334
| 91,015
|
Rallybio Corp.*
|
| 955
| 16,789
|
RAPT Therapeutics, Inc.*
|
| 3,292
| 102,217
|
Recursion Pharmaceuticals, Inc. "A"* (a)
|
| 4,187
| 96,343
|
REGENXBIO, Inc.* (a)
|
| 5,901
| 247,370
|
Relay Therapeutics, Inc.* (a)
|
| 8,988
| 283,392
|
Reneo Pharmaceuticals, Inc.*
|
| 1,096
| 8,165
|
Replimune Group, Inc.*
|
| 4,426
| 131,187
|
REVOLUTION Medicines, Inc.* (a)
|
| 8,861
| 243,766
|
Rhythm Pharmaceuticals, Inc.*
|
| 6,753
| 88,194
|
Rigel Pharmaceuticals, Inc.* (a)
|
| 25,327
| 91,937
|
Rocket Pharmaceuticals, Inc.* (a)
|
| 6,212
| 185,677
|
Rubius Therapeutics, Inc.* (a)
|
| 6,913
| 123,604
|
Sana Biotechnology, Inc.* (a)
|
| 12,941
| 291,431
|
Sangamo Therapeutics, Inc.*
|
| 17,626
| 158,810
|
Scholar Rock Holding Corp.* (a)
|
| 4,110
| 135,712
|
Selecta Biosciences, Inc.* (a)
|
| 13,726
| 57,100
|
Sensei Biotherapeutics, Inc.* (a)
|
| 3,114
| 32,759
|
Sera Prognostics, Inc. "A"*
|
| 516
| 5,733
|
Seres Therapeutics, Inc.*
|
| 10,676
| 74,305
|
Sesen Bio, Inc.* (a)
|
| 26,218
| 20,796
|
Shattuck Labs, Inc.* (a)
|
| 4,078
| 83,110
|
Sigilon Therapeutics, Inc.*
|
| 2,035
| 11,498
|
Silverback Therapeutics, Inc.* (a)
|
| 3,308
| 33,014
|
Solid Biosciences, Inc.*
|
| 9,102
| 21,754
|
Sorrento Therapeutics, Inc.* (a)
|
| 41,874
| 319,499
|
Spectrum Pharmaceuticals, Inc.* (a)
|
| 24,947
| 54,384
|
Spero Therapeutics, Inc.* (a)
|
| 3,443
| 63,386
|
SpringWorks Therapeutics, Inc.*
|
| 4,355
| 276,281
|
Spruce Biosciences, Inc.*
|
| 1,143
| 6,869
|
SQZ Biotechnologies Co.* (a)
|
| 3,478
| 50,153
|
Stoke Therapeutics, Inc.*
|
| 2,923
| 74,361
|
Summit Therapeutics, Inc.*
|
| 3,405
| 17,059
|
Surface Oncology, Inc.*
|
| 5,050
| 38,228
|
Sutro Biopharma, Inc.*
|
| 6,637
| 125,373
|
Syndax Pharmaceuticals, Inc.* (a)
|
| 6,894
| 131,744
|
Syros Pharmaceuticals, Inc.*
|
| 8,330
| 37,235
|
Talaris Therapeutics, Inc.*
|
| 1,360
| 18,442
|
Taysha Gene Therapies, Inc.* (a)
|
| 3,409
| 63,476
|
TCR2 Therapeutics, Inc.*
|
| 4,733
| 40,278
|
Tenaya Therapeutics, Inc.*
|
| 2,043
| 42,188
|
TG Therapeutics, Inc.* (a)
|
| 19,111
| 636,014
|
Tonix Pharmaceuticals Holding Corp.* (a)
|
| 50,002
| 30,056
|
Travere Therapeutics, Inc.*
|
| 8,863
| 214,928
|
Trevena, Inc.*
|
| 25,031
| 30,788
|
Trillium Therapeutics, Inc.*
|
| 15,004
| 263,470
|
Turning Point Therapeutics, Inc.*
|
| 6,883
| 457,238
|
Twist Bioscience Corp.* (a)
|
| 7,073
| 756,599
|
UroGen Pharma Ltd.* (a)
|
| 3,025
| 50,880
|
Vanda Pharmaceuticals, Inc.*
|
| 8,210
| 140,719
|
Vaxart, Inc.* (a)
|
| 18,328
| 145,708
|
Vaxcyte, Inc.* (a)
|
| 6,100
| 154,757
|
VBI Vaccines, Inc.* (a)
|
| 28,377
| 88,252
|